StonvexLoading…
StonvexStonvexStonvexCore line items from SNDK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-27 | Annual 2024 2024-06-28 | Annual 2023 2023-06-30 |
|---|---|---|---|
Revenue | $7.36B | $6.66B | $6.09B |
Operating Income | $-1.38B | $-468.00M | $-2.04B |
Net Income | $-1.64B | $-672.00M | $-2.14B |
EPS (Diluted) | $-11.32 | $-4.63 | $-14.78 |
Total Assets | $12.98B | $13.51B | Not available |
Total Liabilities | $3.77B | $2.42B | Not available |
Cash & Equivalents | $1.48B | $328.00M | $292.00M |
Free Cash Flow OCF − CapEx | $-120.00M | $-475.00M | $-932.00M |
Shares Outstanding | 146.00M | 145.00M | 145.00M |